Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Stefania De Propris

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|December 3, 2005
Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy aloneMaria Luisa Moleti, Anna Maria Testi, Fiorina Giona, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 12, 2024
NG2 Molecule Expression in Acute Lymphoblastic Leukemia B Cells: A Flow-Cytometric Marker for the Rapid Identification of <i>KMT2A</i> Gene RearrangementsMaria Laura Bisegna, Nadia Peragine, Loredana Elia, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2011
Immunocompetent cell functions in Ph+ acute lymphoblastic leukemia patients on prolonged Imatinib maintenance treatmentRoberta Maggio, Nadia Peragine, Maria Stefania De Propris, et al.
Haematologica|March 26, 2003
One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantationAndrea Mengarelli, Anna Paola Iori, Atelda Romano, et al.
Frontiers in Oncology|July 3, 2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRSChiara Masucci, Sara Pepe, Ursula La Rocca, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2023
Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: An Italian Monocentric ExperienceFrancesca Fazio, Gianfranco Lapietra, Maria Zaira Limongi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|December 4, 2012
Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia PatientsSaveria Capria, Silvia Maria Trisolini, Clara Minotti, et al.
Haematologica|September 18, 2012
Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the diseaseMarilisa Marinelli, Nadia Peragine, Valeria Di Maio, et al.
Blood|April 24, 2009
Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 casesIlaria Del Giudice, Sabina Chiaretti, Simona Tavolaro, et al.
Leukemia & Lymphoma|April 28, 2025
CD99 expression in acute myeloid leukemia with FLT3 internal tandem duplications (FLT3-ITD<sup>mut</sup>-AML): a flow-cytometric marker for an accurate diagnostic workupAlessandro Laganà, Deborah Kasmi, Daniela Diverio, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|December 3, 2005
Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy aloneMaria Luisa Moleti, Anna Maria Testi, Fiorina Giona, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 12, 2024
NG2 Molecule Expression in Acute Lymphoblastic Leukemia B Cells: A Flow-Cytometric Marker for the Rapid Identification of <i>KMT2A</i> Gene RearrangementsMaria Laura Bisegna, Nadia Peragine, Loredana Elia, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2011
Immunocompetent cell functions in Ph+ acute lymphoblastic leukemia patients on prolonged Imatinib maintenance treatmentRoberta Maggio, Nadia Peragine, Maria Stefania De Propris, et al.
Haematologica|March 26, 2003
One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantationAndrea Mengarelli, Anna Paola Iori, Atelda Romano, et al.
Frontiers in Oncology|July 3, 2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRSChiara Masucci, Sara Pepe, Ursula La Rocca, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2023
Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: An Italian Monocentric ExperienceFrancesca Fazio, Gianfranco Lapietra, Maria Zaira Limongi, et al.
Mediterranean Journal of Hematology and Infectious Diseases|December 4, 2012
Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia PatientsSaveria Capria, Silvia Maria Trisolini, Clara Minotti, et al.
Haematologica|September 18, 2012
Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the diseaseMarilisa Marinelli, Nadia Peragine, Valeria Di Maio, et al.
Blood|April 24, 2009
Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 casesIlaria Del Giudice, Sabina Chiaretti, Simona Tavolaro, et al.
Leukemia & Lymphoma|April 28, 2025
CD99 expression in acute myeloid leukemia with FLT3 internal tandem duplications (FLT3-ITD<sup>mut</sup>-AML): a flow-cytometric marker for an accurate diagnostic workupAlessandro Laganà, Deborah Kasmi, Daniela Diverio, et al.
Pageof 7